Lianne M Reus1, Bogdan Pasaniuc2, Danielle Posthuma3, Toni Boltz4, Yolande A L Pijnenburg5, Roel A Ophoff6. 1. Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. Electronic address: l.reus@amsterdamumc.nl. 2. Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California; Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, California. 3. Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. 4. Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California. 5. Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. 6. Department of Psychiatry, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California; Center for Neurobehavioral Genetics, University of California, Los Angeles, Los Angeles, California.
Abstract
BACKGROUND: The etiology of frontotemporal dementia (FTD) is poorly understood. To identify genes with predicted expression levels associated with FTD, we integrated summary statistics with external reference gene expression data using a transcriptome-wide association study approach. METHODS: FUSION software was used to leverage FTD summary statistics (all FTD: n = 2154 cases, n = 4308 controls; behavioral variant FTD: n = 1337 cases, n = 2754 controls; semantic dementia: n = 308 cases, n = 616 controls; progressive nonfluent aphasia: n = 269 cases, n = 538 controls; FTD with motor neuron disease: n = 200 cases, n = 400 controls) from the International FTD-Genomics Consortium with 53 expression quantitative loci tissue type panels (n = 12,205; 5 consortia). Significance was assessed using a 5% false discovery rate threshold. RESULTS: We identified 73 significant gene-tissue associations for FTD, representing 44 unique genes in 34 tissue types. Most significant findings were derived from dorsolateral prefrontal cortex splicing data (n = 19 genes, 26%). The 17q21.31 inversion locus contained 23 significant associations, representing 6 unique genes. Other top hits included SEC22B (a gene involved in vesicle trafficking), TRGV5, and ZNF302. A single gene finding (RAB38) was observed for behavioral variant FTD. For other clinical subtypes, no significant associations were observed. CONCLUSIONS: We identified novel candidate genes (e.g., SEC22B) and previously reported risk regions (e.g., 17q21.31) for FTD. Most significant associations were observed in dorsolateral prefrontal cortex splicing data despite the modest sample size of this reference panel. This suggests that our findings are specific to FTD and are likely to be biologically relevant highlights of genes at different FTD risk loci that are contributing to the disease pathology.
BACKGROUND: The etiology of frontotemporal dementia (FTD) is poorly understood. To identify genes with predicted expression levels associated with FTD, we integrated summary statistics with external reference gene expression data using a transcriptome-wide association study approach. METHODS: FUSION software was used to leverage FTD summary statistics (all FTD: n = 2154 cases, n = 4308 controls; behavioral variant FTD: n = 1337 cases, n = 2754 controls; semantic dementia: n = 308 cases, n = 616 controls; progressive nonfluent aphasia: n = 269 cases, n = 538 controls; FTD with motor neuron disease: n = 200 cases, n = 400 controls) from the International FTD-Genomics Consortium with 53 expression quantitative loci tissue type panels (n = 12,205; 5 consortia). Significance was assessed using a 5% false discovery rate threshold. RESULTS: We identified 73 significant gene-tissue associations for FTD, representing 44 unique genes in 34 tissue types. Most significant findings were derived from dorsolateral prefrontal cortex splicing data (n = 19 genes, 26%). The 17q21.31 inversion locus contained 23 significant associations, representing 6 unique genes. Other top hits included SEC22B (a gene involved in vesicle trafficking), TRGV5, and ZNF302. A single gene finding (RAB38) was observed for behavioral variant FTD. For other clinical subtypes, no significant associations were observed. CONCLUSIONS: We identified novel candidate genes (e.g., SEC22B) and previously reported risk regions (e.g., 17q21.31) for FTD. Most significant associations were observed in dorsolateral prefrontal cortex splicing data despite the modest sample size of this reference panel. This suggests that our findings are specific to FTD and are likely to be biologically relevant highlights of genes at different FTD risk loci that are contributing to the disease pathology.
Authors: Nicole C Berchtold; Paul D Coleman; David H Cribbs; Joseph Rogers; Daniel L Gillen; Carl W Cotman Journal: Neurobiol Aging Date: 2012-12-27 Impact factor: 4.673
Authors: Zhihong Zhu; Futao Zhang; Han Hu; Andrew Bakshi; Matthew R Robinson; Joseph E Powell; Grant W Montgomery; Michael E Goddard; Naomi R Wray; Peter M Visscher; Jian Yang Journal: Nat Genet Date: 2016-03-28 Impact factor: 38.330
Authors: Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis Journal: Nature Date: 2015-10-01 Impact factor: 49.962
Authors: Frank P Diekstra; Vivianna M Van Deerlin; John C van Swieten; Ammar Al-Chalabi; Albert C Ludolph; Jochen H Weishaupt; Orla Hardiman; John E Landers; Robert H Brown; Michael A van Es; R Jeroen Pasterkamp; Max Koppers; Peter M Andersen; Karol Estrada; Fernando Rivadeneira; Albert Hofman; André G Uitterlinden; Philip van Damme; Judith Melki; Vincent Meininger; Aleksey Shatunov; Christopher E Shaw; P Nigel Leigh; Pamela J Shaw; Karen E Morrison; Isabella Fogh; Adriano Chiò; Bryan J Traynor; David Czell; Markus Weber; Peter Heutink; Paul I W de Bakker; Vincenzo Silani; Wim Robberecht; Leonard H van den Berg; Jan H Veldink Journal: Ann Neurol Date: 2014-06-27 Impact factor: 10.422
Authors: Fred A Wright; Patrick F Sullivan; Andrew I Brooks; Fei Zou; Wei Sun; Kai Xia; Vered Madar; Rick Jansen; Wonil Chung; Yi-Hui Zhou; Abdel Abdellaoui; Sandra Batista; Casey Butler; Guanhua Chen; Ting-Huei Chen; David D'Ambrosio; Paul Gallins; Min Jin Ha; Jouke Jan Hottenga; Shunping Huang; Mathijs Kattenberg; Jaspreet Kochar; Christel M Middeldorp; Ani Qu; Andrey Shabalin; Jay Tischfield; Laura Todd; Jung-Ying Tzeng; Gerard van Grootheest; Jacqueline M Vink; Qi Wang; Wei Wang; Weibo Wang; Gonneke Willemsen; Johannes H Smit; Eco J de Geus; Zhaoyu Yin; Brenda W J H Penninx; Dorret I Boomsma Journal: Nat Genet Date: 2014-04-13 Impact factor: 38.330
Authors: Alexander Gusev; Nicholas Mancuso; Hyejung Won; Maria Kousi; Hilary K Finucane; Yakir Reshef; Lingyun Song; Alexias Safi; Steven McCarroll; Benjamin M Neale; Roel A Ophoff; Michael C O'Donovan; Gregory E Crawford; Daniel H Geschwind; Nicholas Katsanis; Patrick F Sullivan; Bogdan Pasaniuc; Alkes L Price Journal: Nat Genet Date: 2018-04-09 Impact factor: 38.330
Authors: Andrew D Grotzinger; Javier de la Fuente; Gail Davies; Michel G Nivard; Elliot M Tucker-Drob Journal: Nat Commun Date: 2022-10-21 Impact factor: 17.694